WallStSmart
CPT

Camden Property Trust

NYSE: CPT · REAL ESTATE · REIT - RESIDENTIAL

$104.92
+0.53% today

Updated 2026-06-05

Market cap
$11.39B
P/E ratio
32.12
P/S ratio
7.19x
EPS (TTM)
$3.58
Dividend yield
3.68%
52W range
$95 – $117
Volume
1.2M

Camden Property Trust (CPT) Stock Valuation Analysis

Fair value estimate, historical valuation range, and quality signals for CPT.

WallStSmart Verdict
Overvalued

Current price exceeds what fundamentals support. Risk/reward skewed unfavorably.

Smart Value Score: 49 / 100
P/E (TTM)
32.1x
vs 5Y median of 30.0x
PEG
9.17
Elevated vs growth
Margin of Safety
+13.81%
Fair value $128.50 vs $104.92
EV / EBITDA
12.6x

CPT historical valuation range

Where current P/E sits in CPT's own 5Y range.

NOW
15.7x
5Y Low
28.8x
25th
30.0x
Median
48.3x
75th
123.9x
5Y High
CPT is trading more expensive than 63% of the last 5Y.
63th percentile · Above median

CPT intrinsic value (DCF)

DCF-based fair value estimate vs current market price.

Current price
$104.92
Market value
Intrinsic value
$128.50
DCF estimate
Margin of safety
+13.81%
+22.5% upside to fair value

Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.

CPT valuation signals

Quick-read green flags, caution flags, and risks based on current metrics.

PEG above 2.0
PEG of 9.17 suggests price is running ahead of growth rate. Caution warranted.
!
P/E in mid-range
P/E sits at the 63th percentile of the 5Y range. Neither cheap nor rich historically.
!
Near fair value
+13.81% margin of safety. Price is close to DCF estimate.

P/E Ratio — History

Current: 32.12x

P/S Ratio — History

Current: 7.19x

Is CPT overvalued in 2026?

Camden Property Trust (CPT) currently trades at $104.92 per share with a market capitalization of $11,393,437,000.00. Based on our multi-factor framework, the stock appears richly valued with a Smart Value Score of 49/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.

The stock trades at a P/E ratio of 32.1x, above its 5-year median of 30.0x. The PEG ratio of 9.17 indicates the price has run ahead of the underlying growth rate.

Looking at its own history, CPT is currently trading more expensive than 63% of the last 5Y on P/E. This places it in the 63th percentile of its historical range, a reasonable but unremarkable position.

Our discounted cash flow model estimates CPT's intrinsic value at $128.50 per share, against the current market price of $104.92. This implies a margin of safety of +13.81%. The stock is priced close to its estimated fair value, offering limited upside without further operational improvement.

The Piotroski F-Score of 5/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.

Bottom line: CPT appears richly valued on our framework, with a Smart Value Score of 49/100. At current levels the risk/reward is skewed against the buyer. A materially lower price or significant operational improvement would be needed to change the picture.

Frequently asked questions

Is CPT overvalued?

CPT scores 49/100 on our Smart Value Score (Grade C), a weak overall profile. The DCF also shows a positive margin of safety, so price and fundamentals line up reasonably well.

What is CPT's fair value?

Our DCF model estimates CPT's intrinsic value at $128.50 per share, versus the current price of $104.92, a margin of safety of +13.81%. Fair value is the present value of the cash flows we project the business to produce, so a price below it means the market is pricing the stock below that conservative estimate.

What P/E ratio does CPT trade at?

CPT trades at a P/E of 32.1x on trailing twelve-month earnings, against a 5-year median of 30.0x. P/E is what you pay per dollar of profit, and sitting above its own median means the stock is pricier than usual relative to its earnings.

Is CPT a buy based on valuation?

Our Smart Value rating for CPT is Sell, from a Smart Value Score of 49/100 that blends growth, quality, and valuation. The profile skews cautious, and a better price or clearer operating improvement would strengthen the case. This is research to inform your decision, not personalized financial advice.

How does CPT's valuation compare to its history?

On P/E, CPT sits in the 63rd percentile of its own 5Y range, above its long-run median relative to where it has traded. A high percentile means today's multiple is near the top of its historical band.

What is CPT's Smart Value Score?

CPT's Smart Value Score is 49/100. It is a proprietary WallStSmart metric blending growth quality, financial health, and valuation into a single 0-100 read, and scores above 75 are rare, signaling strong multi-factor alignment.